Regulation of host immune responses by modification of Salmonella virulence genes

Nature Medicine

Volumn 4, Issue 11, 1998, Pages 1247-1252

  Vancott, John L ^a   Chatfield, Stephen N ^b   Roberts, Mark ^c   Hone, David M ^d   Hohmann, Elizabeth L ^e   Pascual, David W ^f   Yamamoto, Masafumi ^g   Kiyono, Hiroshi ^g   Mcghee, Jerry R ^h  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d INSTITUTE OF HUMAN VIROLOGY   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f MONTANA STATE UNIVERSITY   (United States)

^g OSAKA UNIVERSITY   (Japan)

^h University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BACTERIAL GENE; BACTERIAL IMMUNITY; BACTERIAL VIRULENCE; BACTERIUM MUTANT; CONTROLLED STUDY; GENETIC MANIPULATION; HELPER CELL; HOST RESISTANCE; IMMUNE RESPONSE; IMMUNOREGULATION; INOCULATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA;

ANIMALIA; BACTERIA (MICROORGANISMS); NEGIBACTERIA; SALMONELLA;

EID: 0031761449     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/3227     Document Type: Article

References (43)

1. Levine, M.M. et al. Attenuated Salmonella as live oral vaccines against typhoid fever and as live vectors. J. Biotech. 44, 193-196 (1996).
2. Jones, B.D. & Falkow, S. in Annual Review of Immunology Vol. 14 (eds. W.E. Paul, W.E., Fathman, C.G., & Metzger, H.) 533 (Annual Reviews, Palo Alto, California, 1996).
3. Miller, S.I., Kukraal, A.M. & Mekalanos, J.J. A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence. Proc. Natl. Acad. Sci. USA 86, 5054-5058 (1989).
4. VanCott, J.L. et al. The host response to mucosal vaccines in the context of targeted gene knockout mice. Mucosal Immunol. Update 3 4, 12-14 (1995).
5. + TCR-αβ cells and IFN-γ in bacterial clearance independent of intracellular location. J. Immunol. 156, 3321-3326 (1996).
6. Weintraub, B.C. et al. Role of αβ and γδ T cells in the host response to Salmonella infection as demonstrated in T-cell-receptor-deficient mice of defined lty genotypes. Infect. Immun. 65, 2306-2312 (1997).
7. Hoiseth, S.K. & Stocker, B.A.D. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291, 238-239 (1981).
8. Galan, J.E. & R. Curtiss, III., R. Virulence and vaccine potential of phoP mutants of Salmonella typhimurium. Microb. Pathog. 6, 433-443 (1989).
9. Chatfield, S.N. et al. Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine. Bio/Technology 10, 888-892 (1992).
10. Chatfield, S.N. et al. Evaluation of Salmonella typhimurium strains harbouring defined mutations in htrA and aroA in the murine salmonellosis model. Microb. Pathog. 12, 145-151 (1992).
11. Tacket, C.O. et al. Comparison of the safety and immunogenicity of delta aroC delta aroD and delta cya delta crp Salmonella typhi strains in adult volunteers. Infect. Immun. 60, 536-541 (1992).
12. Hohmann, E.L., Oletta, C.A. & Miller, S.I. Evaluation of a phoP/phoQ-deleted, aroA-deleted live oral Salmonella typhi vaccine strain in human volunteers. Vaccine 14, 19-24 (1996).
13. Dalton, D.K. et al. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259, 1739-1742 (1993).
14. Mombaerts, P. et al. Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages. Nature 360, 225-231 (1992).
15. Itohara, S. et al. T cell receptor delta gene mutant mice: independent generation of alpha beta T cells and programmed rearrangements of gamma delta TCR genes. Cell 72, 337-348 (1993).
16. Miller, S.I. & Mekalanos, J.J. Constitutive expression of the phoP regulon attenuates Salmonella virulence and survival within macrophages. J. Bacteriol. 172, 2485-2490 (1990).
17. Curtiss, R. & Kelly, S.M. Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic. Infect. Immun. 55, 3035-3043 (1987).
18. Snapper, C.F. & Finkelman, F.D. in Fundamental Immunology 3rd edn. (ed. Paul, W.E.) 837-863 (Raven, New York, 1993).
19. De Groote, M.A., Testerman, T., Xu, Y., Stauffer, G., & Fang, F.C. Homocysteine antagonism of nitric oxide-related cytostasis in Salmonella typhimurium. Science 272, 414-417 (1996).
20. Umezawa, K.H. et al. Induction of nitric oxide synthesis and xanthine oxidase and their roles in the antimicrobial mechanism against Salmonella typhimurium infection in mice. Infect. Immun. 65, 2932-2940 (1997).
21. Edwards III, C.K. et al. In vivo administration of recombinant growth hormone or gamma interferon activates macrophages: enhanced resistance to experimental Salmonella typhimurium infection is correlated with generation of reactive oxygen intermediates. Infect. Immun. 60, 2514-2521 (1992).
22. Wright, S.D., Ramos, R.A., Tobias, P.S., Ulevitch, R.J., & Mathison, J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein Science 249, 1431-1433 (1990).
23. Guo, L. et al. Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science 11, 250-253 (1997).
24. Vidal, S. et al. The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene. J. Exp. Med. 182, 655-656 (1995).
25. Lissner, C.R. Swanson, R.N. & O'Brien, A.D. Genetic control of the innate resistance of mice to Salmonella typhimurium: expression of the lty gene in peritoneal and splenic macrophages isolated in vitro. J. Immunol. 131, 3006-3013 (1983).
26. Thiemermann, C. The role of the L-Arginine: nitric oxide pathway in circulatory shock. Adv. Pharmacol. 28, 45-79 (1994).
27. Gotschlich, E.C. in Fundamental Immunology 3rd edn. (ed. Paul, W.E.) 1287-1308 (Raven, New York, 1993).
28. al-Ramadi, B.K., Brodkin, M.A., Mosser, D.M., & Eisenstein, T.K. Immunosuppression induced by attenuated Salmonella. J. Immunol. 146, 2737-2746 (1991).
29. al-Ramadi, B.K., Meiss, Jr., J.J., Huang, D., & Eisenstein, T.K. Immunosuppression induced by nitric oxide and its inhibition by interleukin-4. Eur. J. Immunol. 22, 2249-2254 (1992).
30. Miller, S.I., Pulkkinen, W.S., Selsted, M.E. & Mekalanos, J.J. Characterization of defensin resistance phenotypes associated with mutations in the phoP virulence regulon of Salmonella typhimurium. Infect. Immun. 58, 3706-3710 (1990).
31. Miller, S.I. PhoP/PhoQ: macrophage-specific modulators of Salmonella virulence? Mol. Microbiol. 5, 2073-2078 (1991).
32. Gunn, J.S. & Miller, S.I. PhoP-PhoQ activates transcription of pmrAB, encoding a two-component regulatory system involved in Salmonella typhimurium antimicrobial peptide resistance. J. Bacteriol. 178, 6857-6864 (1996).
33. Soncini, F.C., Vescovi, G.E., Solmon, F., & Groisman, E.A. Molecular basis of the magnesium deprivation response in Salmonella typhimurium: identification of PhoP-regulated genes. J. Bacteriol. 178, 5092-5099 (1996).
34. Cowley, S.C., Myltseva, S.V. & Nano, F.E. Phase variation in Francisella tularensis affecting intracellular growth, lipopolysaccharide antigenicity and nitric oxide production. Mol. Microbiol. 20, 867-874 (1996).
35. Eisenstein, T.K., Meissler J.J. Jr., Miller, S.I. & Stocker B.A.D. Immunosuppression and nitric oxide production induced by parenteral live Salmonella vaccines do not correlate with protective capacity: a phoP::Tn10 mutant does not suppress but does protect. Vaccine 16, 24-32 (1998).
36. Pawelek, J.M., Low, K.B. & Bermudes, D. Tumor-targeted Salmonella as a novel anticancer vector. Cancer Res. 57, 4537-4544 (1997).
37. 15N]nitrate in biological fluids. Anal. Biochem. 126, 131-138 (1982).
38. Gangadharam, P.R. & Edwards III, C.K. Release of superoxide anion from resident and activated mouse peritoneal macrophages infected with Mycobacterium intracellulare. Am. Rev. Respir. Dis. 130, 834-838 (1984).
39. Darveau, R.P. & Hancock, R.E. Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains. J. Bacteriol. 155, 831-838 (1983).
40. VanCott. J.L. et al. Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella. J. Immunol. 156, 1504-1514 (1996).
41. Fujihashi, K. et al. in Methods of Microbiology: Immunology of Infection (eds. Kaufman, S.H.E. & Kabelitz, D.) 257-286 (Academic, San Diego, 1998).
42. Yang, J., Kawamura, I., Zhu, H., & Mitsuyama, M. Involvement of natural killer cells in nitric oxide production by spleen cells after stimulation with Mycobacterium bovis BCG. J. Immunol. 155, 5728-5735 (1995).
43. Szalai, A.J., Briles, D.E. & Volanakis, J.E. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice. J. Immunol. 155, 2557-2563 (1995).